Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             252 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Aberrations of the p53 and RB tumor suppressor genes in squamous cell carcinomas of the lung 1994
 10 5-6 p. 390-391
2 p.
 artikel
2 Activation of coagulation and fibrinolysis in patients with lung cancer: Relation to tumour stage and prognosis 1994
 10 5-6 p. 414-
1 p.
 artikel
3 Adjuvant treatment of stage I lung cancer with high-dose vitamin A 1994
 10 5-6 p. 426-
1 p.
 artikel
4 A homozygous deletion on chromosome 3 in a small cell lung cancer cell line correlates with a region of tumor suppressor activity 1994
 10 5-6 p. 401-
1 p.
 artikel
5 Allelotypes of squamous cell carcinomas of the lung 1994
 10 5-6 p. 391-
1 p.
 artikel
6 Altered blood group antigen expression as a new prognostic factor in non-small-cell lung cancer 1994
 10 5-6 p. 360-361
2 p.
 artikel
7 Altered drug distribution and elevated expression of a novel transporter gene (MRP) in a multidrug resistant lung cancer cell line 1994
 10 5-6 p. 350-351
2 p.
 artikel
8 Alternating chemotherapy and twice-daily thoracic radiotherapy in limited- stage small-cell lung cancer: A pilot study of the Eastern Cooperative Oncology Group 1994
 10 5-6 p. 427-428
2 p.
 artikel
9 Alternating chemotherapy in advanced non-small cell lung cancer: A phase II study 1994
 10 5-6 p. 418-
1 p.
 artikel
10 Amino acid amidation motifs: a signal of biological activity 1994
 10 5-6 p. 351-
1 p.
 artikel
11 Analysis of long-term survivors with small-cell lung cancer 1994
 10 5-6 p. 413-
1 p.
 artikel
12 Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines 1994
 10 5-6 p. 424-
1 p.
 artikel
13 Ancillary therapies in the management of lung cancer: Photodynamic therapy, laser therapy, and endobronchial prosthetic devices 1994
 10 5-6 p. 428-
1 p.
 artikel
14 An emerging role for photodynamic therapy in lung cancer 1994
 10 5-6 p. 428-
1 p.
 artikel
15 Announcements 1994
 10 5-6 p. 381-383
3 p.
 artikel
16 An observation and study on the incidence and causes of NSCLC and SCC Yurun, L
 1994
 10 5-6 p. 387-
1 p.
 artikel
17 A novel protein associated with cancer multidrug resistance 1994
 10 5-6 p. 351-352
2 p.
 artikel
18 A novel small cell lung carcinoma-specific DNA-binding activity related to the transcription factor AP-1 1994
 10 5-6 p. 406-
1 p.
 artikel
19 A phase I trial of ifosfamide, mesna, and cisplatin in advanced non-small cell lung cancer: A cancer and leukemia group B study 1994
 10 5-6 p. 419-
1 p.
 artikel
20 A pilot study about efficacy of immunostimulating therapy in patients radically operated for non small cell lung cancer (stage I). Early results 1994
 10 5-6 p. 429-
1 p.
 artikel
21 Approaches to studying premalignant changes in the respiratory epithelium 1994
 10 5-6 p. 354-355
2 p.
 artikel
22 A prospective analysis of chemotherapy following surgical resection of clinical stage I-II small-cell lung cancer 1994
 10 5-6 p. 428-
1 p.
 artikel
23 A review of the literature on the treatment for locally advanced squamous cell carcinoma of the lung 1994
 10 5-6 p. 394-
1 p.
 artikel
24 Asbestos and lung cancer in Glasgow and the west of Scotland 1994
 10 5-6 p. 399-
1 p.
 artikel
25 Asbestos-related pleural plaques and lung cancer 1994
 10 5-6 p. 410-
1 p.
 artikel
26 Aspects of quality of life in patients with lung cancer: A three observer evaluation study 1994
 10 5-6 p. 413-
1 p.
 artikel
27 A study of tobacco carcinogenesis: Effect of the fat content of the diet on the carcinogenic activity of 4-(methylnitrosamino)-1-(3-pyridyl)-1- butanone in F344 rats 1994
 10 5-6 p. 397-
1 p.
 artikel
28 A survey of the Czechoslovak follow-up of lung cancer mortality in uranium miners 1994
 10 5-6 p. 401-
1 p.
 artikel
29 Atrial natriuretic factor production, atrial natriuretic factor receptors, and their effect on small cell lung cancer cells 1994
 10 5-6 p. 358-
1 p.
 artikel
30 Binding of cellular proteins to the conformational domain of p53 1994
 10 5-6 p. 364-
1 p.
 artikel
31 Blood vessel invasion by tumor cells predicts recurrence in completely resected T1 N0 M0 non-small-cell lung cancer 1994
 10 5-6 p. 415-416
2 p.
 artikel
32 Bombesin-like peptides, neuroendocrine cells and pulmonary carcinogenesis 1994
 10 5-6 p. 364-
1 p.
 artikel
33 Bronchial carcinoid tumors 1994
 10 5-6 p. 407-
1 p.
 artikel
34 Bronchoalveolar lavage fluid findings following radiotherapy for non- small cell lung cancer 1994
 10 5-6 p. 426-
1 p.
 artikel
35 Bronchoplastic and angioplastic techniques in the treatment of bronchogenic carcinoma 1994
 10 5-6 p. 416-
1 p.
 artikel
36 Bronchoscopic ultrasonography for diagnosis in roentgenologically occult carcinoma of the tracheobronchial tree 1994
 10 5-6 p. 392-
1 p.
 artikel
37 Calcitonin gene-related peptide in small cell lung carcinomas 1994
 10 5-6 p. 408-
1 p.
 artikel
38 Calcitriol increases adriamycin sensitivity in human non-small cell lung cancer cells 1994
 10 5-6 p. 420-421
2 p.
 artikel
39 Cardiopulmonary function after pulmonary lobectomy in patients with lung cancer 1994
 10 5-6 p. 410-
1 p.
 artikel
40 CARET, the beta-carotene and retinal efficacy trial to prevent lung cancer in high-risk populations 1994
 10 5-6 p. 396-
1 p.
 artikel
41 Changes in cell population and tumor necrosis factor, interleukin-6, and interleukin-8 in malignant pleural effusions after treatment with intrapleural tetracycline 1994
 10 5-6 p. 387-
1 p.
 artikel
42 Changing trends in histologic types of lung cancer during the last decade (1981–1990) in Korea: a hospital-based study Choi, Jin-Hyuk
 1994
 10 5-6 p. 287-296
10 p.
 artikel
43 Characterisation of a vindesine-resistant human small-cell lung cancer cell line 1994
 10 5-6 p. 419-
1 p.
 artikel
44 Characterization of p53 mutations in methylene chloride-induced lung tumors from B6C3F1 mice 1994
 10 5-6 p. 404-
1 p.
 artikel
45 Chemotherapy and radiation for the treatment of non-small-cell lung cancer: A critical review 1994
 10 5-6 p. 428-
1 p.
 artikel
46 Chest tumor response during lung cancer chemotherapy: Computed tomography vs fiberoptic bronchoscopy 1994
 10 5-6 p. 412-
1 p.
 artikel
47 Chronic effects of subuctaneous interleukin-2 therapy on soluble interleukin-2 receptors in advanced small cell lung cancer 1994
 10 5-6 p. 424-
1 p.
 artikel
48 Cisplatin-cyclophosphamide-mitomycin combination chemotherapy with supportive care versus supportive care alone for treatment of metastatic non- small-cell lung cancer 1994
 10 5-6 p. 421-
1 p.
 artikel
49 Cisplatin, 5-fluorouracil, and etoposide for advanced non-small cell lung cancer 1994
 10 5-6 p. 422-
1 p.
 artikel
50 Clinical complete response to a murine monoclonal antibody (2A11) directed against gastrin releasing peptide in a patient with small cell lung cancer 1994
 10 5-6 p. 359-
1 p.
 artikel
51 Clinical evaluation of serum tumour marker CA 242 in non-small cell lung cancer 1994
 10 5-6 p. 411-
1 p.
 artikel
52 Clinical utility of Gd-DTPA-enhanced magnetic resonance imaging in lung cancer 1994
 10 5-6 p. 412-
1 p.
 artikel
53 Combination chemotherapy with or without thoracic radiotherapy in limited- stage small-cell lung cancer: A randomized trial of the Southeastern Cancer Study Group 1994
 10 5-6 p. 426-
1 p.
 artikel
54 Combination chemotherapy with teniposide (VM26) and carboplatin in small cell lung cancer 1994
 10 5-6 p. 417-
1 p.
 artikel
55 Communicating the diagnosis of lung cancer 1994
 10 5-6 p. 430-
1 p.
 artikel
56 Comparison of the Wang 19-gauge and 22-gauge needles in the mediastinal staging of lung cancer 1994
 10 5-6 p. 411-
1 p.
 artikel
57 Complementary DNA sequence encoding the major neural cell adhesion molecule isoform in a human small cell lung cancer cell line Saito, Shin'ichi
 1994
 10 5-6 p. 307-318
12 p.
 artikel
58 Co-ordinate expression in human lung cancer cell lines of genes of prohormone processing (PAM) and neuroendocrine phenotype (dopa decarboxylase) 1994
 10 5-6 p. 372-373
2 p.
 artikel
59 Correlation of expression of ABH blood group carbohydrate antigens with metastatic potential in human lung carcinomas 1994
 10 5-6 p. 403-
1 p.
 artikel
60 Current status of lung cancer diagnosis and treatment in Shanghai Liao, M.L.
 1994
 10 5-6 p. 333-338
6 p.
 artikel
61 Current treatment of unresectable lung cancer 1994
 10 5-6 p. 427-
1 p.
 artikel
62 CYFRA 21-1: A new marker in lung cancer 1994
 10 5-6 p. 408-
1 p.
 artikel
63 Cytokinetic analysis of lung cancer by in vivo bromodeoxyuridine labelling 1994
 10 5-6 p. 404-
1 p.
 artikel
64 [D-Arg1, D-Phe5, D-Trp7,9, Leu11] substance P inhibits the growth of human small cell lung cancer xenografts in vivo 1994
 10 5-6 p. 403-
1 p.
 artikel
65 Demonstration of nucleolar organizer regions in lung carcinoma by silver staining 1994
 10 5-6 p. 407-
1 p.
 artikel
66 Denaturing gradient gel electrophoresis (DGGE) assay for K-ras and N-ras genes: detection of K-ras point mutations in human lung tumour DNA 1994
 10 5-6 p. 402-
1 p.
 artikel
67 Detailed deletion mapping of the short arm of chromosome 3 in small cell and non-small cell carcinoma of the lung Hosoe, Shigeto
 1994
 10 5-6 p. 297-305
9 p.
 artikel
68 Detection of a novel lung adenocarcinoma — Associated serum antigen defined by two monoclonal antibodies, KM 432 and KM 227 1994
 10 5-6 p. 401-
1 p.
 artikel
69 Diesel exhaust exposure and smoking: A case-referent study of lung cancer among Swedish dock workers 1994
 10 5-6 p. 399-
1 p.
 artikel
70 Differential growth regulation of a metastatic human lung carcinoma cell line through activation of phosphatidyl inositol turnover signal transduction pathway 1994
 10 5-6 p. 402-
1 p.
 artikel
71 DNA abnormalities accumulated in human non-small cell carcinomas of the lung: Aberrations of the ras, p53 and RB genes detected by single-strand conformation analysis of polymerase chain reaction products 1994
 10 5-6 p. 369-
1 p.
 artikel
72 DNA adducts as a measure of lung cancer risk in humans exposed to polycyclic aromatic hydrocarbons 1994
 10 5-6 p. 398-
1 p.
 artikel
73 DNA adducts as biomarkers for assessing exposure to polycyclic aromatic hydrocarbons in tissues from Xuan Wei women with high exposure to coal combustion emissions and high lung cancer mortality 1994
 10 5-6 p. 397-398
2 p.
 artikel
74 Double blind randomized trial of immunotherapy with ubenimex (NK421) on inoperable squamous cell lung cancer patients 1994
 10 5-6 p. 394-
1 p.
 artikel
75 Effect of suramin treatment on mesothelioma and other lung cancer derived cell lines 1994
 10 5-6 p. 423-
1 p.
 artikel
76 Effects of a dominant-negative inhibitor of c-jun in lung cancer cell lines Brown, P
 1994
 10 5-6 p. 349-
1 p.
 artikel
77 Elevated levels of the carcinogen-metabolizing aromatic hydroxylase (product of the CYP1A1 gene) in human lung cancer are the result of alterations in trans-acting regulatory mechanisms 1994
 10 5-6 p. 358-359
2 p.
 artikel
78 Enhanced antitumor efficacy of a combination of CPT-11, a new derivative of camptothecin, and cisplatin against human lung tumor xenografts 1994
 10 5-6 p. 425-
1 p.
 artikel
79 Epidemiological studies on lung cancer in the Bohemia region Marel, M.
 1994
 10 5-6 p. 325-331
7 p.
 artikel
80 Epidemiology and etiology of lung cancer 1994
 10 5-6 p. 429-430
2 p.
 artikel
81 Evaluation for operation with residual tumor on stump of squamous cell lung cancer 1994
 10 5-6 p. 389-
1 p.
 artikel
82 Evaluation of cisplatin intensity in metastatic non-small-cell lung cancer: A phase III study of the Southwest Oncology Group 1994
 10 5-6 p. 421-422
2 p.
 artikel
83 Evaluation of serum neural cell adhesion molecule as a new tumor marker in small cell lung cancer 1994
 10 5-6 p. 409-410
2 p.
 artikel
84 Evidence of a direct relationship between the increase in the in vitro passage number of human non-small-cell-lung cancer primocultures and their chemosensitivity 1994
 10 5-6 p. 418-
1 p.
 artikel
85 Evolution of altered DNA methylation patterns during lung tumor progression 1994
 10 5-6 p. 349-350
2 p.
 artikel
86 Experience with mitomycin in the treatment of non-small cell lung cancer 1994
 10 5-6 p. 422-423
2 p.
 artikel
87 Experimental studies to assess the potential of photodynamic therapy for the treatment of bronchial carcinomas 1994
 10 5-6 p. 428-429
2 p.
 artikel
88 Expression of cyclins and cyclin-dependent protein kinases in lung tumor-derived cell lines 1994
 10 5-6 p. 368-
1 p.
 artikel
89 Expression of IGF-I mRNA in lung cancer cell lines 1994
 10 5-6 p. 366-
1 p.
 artikel
90 Expression of myc family oncoproteins in small-cell lung-cancer cell lines and xenografts 1994
 10 5-6 p. 405-
1 p.
 artikel
91 Expression of transforming growth factor β (TGFβ) receptors and expression of TGFβ1, TGFβ2 and TGFβ3 in human small cell lung cancer cell lines 1994
 10 5-6 p. 405-
1 p.
 artikel
92 Extended operations for T3 and T4 squamous cell carcinoma of the lung 1994
 10 5-6 p. 393-394
2 p.
 artikel
93 Factors which influence the drug sensitivity and resistance in SCLC 1994
 10 5-6 p. 368-369
2 p.
 artikel
94 FOM: An effective, non-cisplatin-based combination chemotherapy for advanced non-small-cell lung cancer with low toxicity 1994
 10 5-6 p. 417-
1 p.
 artikel
95 Genetic abnormalities in quamous cell carcinoma of the lung 1994
 10 5-6 p. 390-
1 p.
 artikel
96 Germ line polymorphisms of p53 and CYP1A1 genes involved in human lung cancer 1994
 10 5-6 p. 403-
1 p.
 artikel
97 Glucocorticoid inhibition of ACTH peptides: Small cell lung cancer cell lines are more resistant than pituitary corticotroph adenoma cells 1994
 10 5-6 p. 405-
1 p.
 artikel
98 Granulocyte-macrophage colony-stimulating factor increases dose intensity of chemotherapy in small cell lung cancer: Relationship between clinical results, peripheral blood cell modifications, and bone marrow kinetics 1994
 10 5-6 p. 417-
1 p.
 artikel
99 Growth inhibition and change in morphology and motility of SCLC cell lines by hepatocyte growth factor/scatter factor 1994
 10 5-6 p. 404-
1 p.
 artikel
100 Heterogeneous expression of oncogenes in small cell lung cancer xenografts 1994
 10 5-6 p. 405-406
2 p.
 artikel
101 How does iliac crest bone marrow biopsy compare with imaging in the detection of bone metastases in small cell lung cancer? 1994
 10 5-6 p. 408-409
2 p.
 artikel
102 IASLC calendar 1994
 10 5-6 p. 384-385
2 p.
 artikel
103 IASLC workshop on improving quality of life and the supportive management of patients with lung cancer Abratt, Raymond P.
 1994
 10 5-6 p. 375-380
6 p.
 artikel
104 Immunophenotypic changes associated with neoplastic transformation of human respiratory tract epithelium 1994
 10 5-6 p. 353-354
2 p.
 artikel
105 Immunoscintigraphy of small-cell lung cancer: A study using technetium and indium labelled anti-carcinoembryonic antigen monoclonal antibody preparations 1994
 10 5-6 p. 411-
1 p.
 artikel
106 Immunotherapy with intralesional and systemic interleukin-2 of patients with non-small-cell lung cancer 1994
 10 5-6 p. 419-
1 p.
 artikel
107 Immunotoxin therapy of small-cell lung cancer: N901-blocked ricin for relapsed small-cell lung cancer 1994
 10 5-6 p. 429-
1 p.
 artikel
108 Impact of hematopoietic growth factors on the management of small-cell lung cancer 1994
 10 5-6 p. 424-
1 p.
 artikel
109 Induction chemotherapy for locally advanced non-small cell lung cancer 1994
 10 5-6 p. 427-
1 p.
 artikel
110 Insulin-like growth factors and their binding proteins in lung cancer 1994
 10 5-6 p. 356-
1 p.
 artikel
111 Interferon-α and interferon-gamma combined with chemotherapy: In vitro sensitivity studies in non-small cell lung cancer cell lines 1994
 10 5-6 p. 419-
1 p.
 artikel
112 Intraperitoneal cultivation of small-cell carcinoma induces expression of the retinal cancer-associated retinopathy antigen 1994
 10 5-6 p. 401-402
2 p.
 artikel
113 Investigation of new agents in small-cell lung cancer 1994
 10 5-6 p. 424-425
2 p.
 artikel
114 In vitro characterization of lung cancers by the use of 1H nuclear magnetic resonance spectroscopy of tissue extracts and discriminant factor analysis 1994
 10 5-6 p. 406-
1 p.
 artikel
115 In vivo study of vinorelbine associations with cisplatin, 5-fluorouracil or actinomycin D relative to a non-small-cell lung carcinoma (NSCLCN6-L16) 1994
 10 5-6 p. 421-
1 p.
 artikel
116 Is bilobectomy superior to lobectomy in treating non-small cell lung cancer (NSCLC) of the right lower lung field? 1994
 10 5-6 p. 387-388
2 p.
 artikel
117 Is T factor of the TNM staging system a predominant prognostic factor in pathologic stage I non-small-cell lung cancer? A multivariate prognostic factor analysis of 151 patients 1994
 10 5-6 p. 415-
1 p.
 artikel
118 K-ras and p53 mutations in rodent lung tumors 1994
 10 5-6 p. 348-349
2 p.
 artikel
119 K-ras oncogene activation in lung adenocarcinomas from former smokers: Evidence that K-ras mutations are an early and irreversible event in the development of adenocarcinoma of the lung 1994
 10 5-6 p. 403-
1 p.
 artikel
120 Late relapse of small cell lung cancer treated with radiation therapy alone — case report Saito, Yoshihiro
 1994
 10 5-6 p. 319-324
6 p.
 artikel
121 Leukocyte alkaline phosphatase and lung cancer patients 1994
 10 5-6 p. 409-
1 p.
 artikel
122 Limited bronchial resection for early hilar squamous cell carcinoma 1994
 10 5-6 p. 392-393
2 p.
 artikel
123 Long-term results of postoperative intrathoracic chemothermotherapy for lung cancer with pleural dissemination 1994
 10 5-6 p. 426-427
2 p.
 artikel
124 Lung cancer after radiation therapy for breast cancer 1994
 10 5-6 p. 425-426
2 p.
 artikel
125 Lung cancer among butchers and slaughterhouse workers 1994
 10 5-6 p. 397-
1 p.
 artikel
126 Lung cancer among textile workers in the Prato area of Italy 1994
 10 5-6 p. 401-
1 p.
 artikel
127 Lung cancer incidence rate for male ex-smokers according to age at cessation of smoking 1994
 10 5-6 p. 395-
1 p.
 artikel
128 Lung cancer in the Schneeberg mines: A reappraisal of the data reported by Harting and Hesse in 1879 1994
 10 5-6 p. 401-
1 p.
 artikel
129 Lung cancer in young patients (aged less 40 years) 1994
 10 5-6 p. 410-
1 p.
 artikel
130 Lung cancer patterns in Switzerland: A search for geographical and occupational patterns 1994
 10 5-6 p. 400-
1 p.
 artikel
131 Lung cancer's persistent association with population density in Los Angeles County communities 1994
 10 5-6 p. 400-
1 p.
 artikel
132 Lung perfusion SPECT in predicting postoperative pulmonary function in lung cancer 1994
 10 5-6 p. 409-
1 p.
 artikel
133 Lymphocyte subsets in patients with lung cancer treated with thiophosphoric acid alkaloid derivatives from Chelidonium majus L. (Ukrain) 1994
 10 5-6 p. 406-
1 p.
 artikel
134 Maintenance chemotherapy in small-cell lung cancer: Long-term results of a randomized trial 1994
 10 5-6 p. 418-
1 p.
 artikel
135 Malignancy associated changes in bronchial epithelial cells 1994
 10 5-6 p. 359-360
2 p.
 artikel
136 Malignant pleural mesothelioma: Distribution of lymphocyte subsets in pleural fluid, bronchoal veolar lavage and peripheral blood 1994
 10 5-6 p. 412-
1 p.
 artikel
137 Malignant pleural mesothelioma: Multivariate analysis of prognostic factors on 113 patients 1994
 10 5-6 p. 408-
1 p.
 artikel
138 Mammalian bombesin receptor signalling in health and disease 1994
 10 5-6 p. 347-348
2 p.
 artikel
139 Management of small-cell lung cancer 1994
 10 5-6 p. 429-
1 p.
 artikel
140 Management of superior vena cava syndrome (SVCS) with lung cancer — analysis of 320 patients 1994
 10 5-6 p. 389-
1 p.
 artikel
141 Marked reduction of type I keratin (K14) in cisplatin-resistant human lung squamous-carcinoma cell lines 1994
 10 5-6 p. 423-
1 p.
 artikel
142 Mediastinal lymph node dissection in resected lung cancer: Morbidity and accuracy of staging 1994
 10 5-6 p. 416-
1 p.
 artikel
143 Metastasis-induced acute pancreatitis as the initial manifestation of bronchogenic carcinoma 1994
 10 5-6 p. 409-
1 p.
 artikel
144 Mitomycin, ifosfamide, and cisplatin in non-small cell lung cancer 1994
 10 5-6 p. 422-
1 p.
 artikel
145 Modulation of oncogene and tumor suppressor gene expression for prevention and therapy of lung cancer 1994
 10 5-6 p. 367-368
2 p.
 artikel
146 Molecular features of tumor cells expressing multidrug resistance due to alterations in DNA topoisomerase IIα 1994
 10 5-6 p. 348-
1 p.
 artikel
147 Monoclonal antibody treatment of small cell lung cancer 1994
 10 5-6 p. 371-372
2 p.
 artikel
148 Mortality from lung cancer among copper miners 1994
 10 5-6 p. 397-
1 p.
 artikel
149 New directions for chemotherapy in non-small-cell lung cancer 1994
 10 5-6 p. 425-
1 p.
 artikel
150 Novel chemotherapeutic agents in the treatment of non-small-cell lung cancer 1994
 10 5-6 p. 418-
1 p.
 artikel
151 Oral verapamil with chemotherapy for advanced non-small cell lung cancer: a randomised study 1994
 10 5-6 p. 411-412
2 p.
 artikel
152 Overexpression of oncoproteins in non-small cell lung carcinomas of smokers 1994
 10 5-6 p. 397-
1 p.
 artikel
153 Palliation of symptoms in non-small cell lung cancer: A Study by the Yorkshire Regional Cancer Organisation Thoracic Group 1994
 10 5-6 p. 413-
1 p.
 artikel
154 p53 Alterations in non-small cell lung cancers correlate with metastatic involvement of hilar and mediastinal lymph nodes 1994
 10 5-6 p. 403-
1 p.
 artikel
155 p53 and prognosis 1994
 10 5-6 p. 350-
1 p.
 artikel
156 Passive smoking and protection of nonsmokers at the workplace 1994
 10 5-6 p. 395-396
2 p.
 artikel
157 Pathological characteristics of squamous cell carcinoma of the lung 1994
 10 5-6 p. 390-
1 p.
 artikel
158 Patterns of p53 and proliferating cell nuclear antigen (PCNA) expression in non-small cell lung cancer: an immunohistochemical study with clinicopathological correlation 1994
 10 5-6 p. 352-
1 p.
 artikel
159 Peptide receptor antagonists and lung cancer 1994
 10 5-6 p. 364-365
2 p.
 artikel
160 Peripheral airway cell differentiation in neoplastic and non-neoplastic lung 1994
 10 5-6 p. 361-
1 p.
 artikel
161 Peripheral blood mononuclear cells express antigens associated with multidrug resistance in a small cell lung cancer cell line 1994
 10 5-6 p. 402-
1 p.
 artikel
162 p53 expression in non small cell lung cancer: Clinical and biological correlations 1994
 10 5-6 p. 408-
1 p.
 artikel
163 Pharmacodynamics of prolonged oral etoposide in patients with advanced non-small-cell lung cancer 1994
 10 5-6 p. 420-
1 p.
 artikel
164 Pharmacokinetics and pharmacodynamics of doxorubicin in patients with small cell lung cancer 1994
 10 5-6 p. 420-
1 p.
 artikel
165 Phase I and pharmacological study of the pulmonary cytotoxin 4-ipomeanol on a single dose schedule in lung cancer patients: Hepatotoxicity is dose limiting in humans 1994
 10 5-6 p. 424-
1 p.
 artikel
166 Phase I/II trial of etoposide and carboplatin in extensive small-cell lung cancer 1994
 10 5-6 p. 425-
1 p.
 artikel
167 Phase II study of a 72-h concurrent continuous infusion of cisplatin and etoposide in advanced non-small-cell lung cancer 1994
 10 5-6 p. 423-
1 p.
 artikel
168 Phase II study of carboplatin and adriamycin as second line chemotherapy in small cell lung cancer 1994
 10 5-6 p. 423-
1 p.
 artikel
169 Phase II study of 4′-iodo-4′-deoxydoxorubicin in non-resectable non-small-cell lung cancer 1994
 10 5-6 p. 417-418
2 p.
 artikel
170 Phase II study of sulofenur (LY 186641): A novel antineoplastic agent in advanced non-small cell lung cancer 1994
 10 5-6 p. 419-420
2 p.
 artikel
171 Phase II trial of gallium nitrate in previously treated patients with small cell lung cancer 1994
 10 5-6 p. 420-
1 p.
 artikel
172 Phase II trial of 6-thioguanine administered as 120 hour continuous infusion for refractory or recurrent small cell lung cancer: A Southwest Oncology Group study 1994
 10 5-6 p. 420-
1 p.
 artikel
173 Phenotypes and lymphokine-activated killer activity of pleural cavity lymphocytes of lung cancer patients without malignant effusion 1994
 10 5-6 p. 410-411
2 p.
 artikel
174 Photodynamic therapy as an alternative treatment for surgery in a patient with lung cancer undergoing bone marrow transplantation 1994
 10 5-6 p. 428-
1 p.
 artikel
175 Photodynamic therapy in squamous cell carcinoma of the lung 1994
 10 5-6 p. 392-
1 p.
 artikel
176 Pituitary adenylate cyclase activating polypeptide receptors are present on small cell lung cancer cells 1994
 10 5-6 p. 407-
1 p.
 artikel
177 p53 mutational spectrum in human cancers: clues to cancer etiology and molecular pathogenesis 1994
 10 5-6 p. 355-356
2 p.
 artikel
178 p53 mutations and 3p deletions in human lung cancer 1994
 10 5-6 p. 366-367
2 p.
 artikel
179 Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population 1994
 10 5-6 p. 396-397
2 p.
 artikel
180 Postoperative complications after combined neoadjuvant treatment of lung cancer 1994
 10 5-6 p. 416-
1 p.
 artikel
181 Preoperative chemotherapy for stage IIIa (N2) lung cancer: The Sloan-Kettering experience with 136 patients 1994
 10 5-6 p. 427-
1 p.
 artikel
182 Presence of mutagen and carcinogen in resected lung specimens with carcinoma in Japan and China in relation to environment 1994
 10 5-6 p. 369-370
2 p.
 artikel
183 Prognostic factors in lung cancer based on multivariate analysis 1994
 10 5-6 p. 407-408
2 p.
 artikel
184 Prolonged, alternating chemotherapy for extensive small cell lung cancer: A Southwest Oncology Group study 1994
 10 5-6 p. 421-
1 p.
 artikel
185 Protease activities in normal human serum and malignant tumor cell extracts which degrade the mitogen IBE1-amide peptide 1994
 10 5-6 p. 363-364
2 p.
 artikel
186 Radiation-associated lung cancer: A comparison of the histology of lung cancers in uranium miners and survivors of the atomic bombings of Hiroshima and Nagasaki 1994
 10 5-6 p. 399-
1 p.
 artikel
187 Radical operation using cardiopulmonary bypass for lung cancer invading the aortic wall 1994
 10 5-6 p. 416-
1 p.
 artikel
188 Radioimmunodetection of lung cancer with IMACIS-1, I-131 labeled monoclonal antibodies to CEA and CA19-9. Comparison of accumulations in irradiated and non-irradiated site 1994
 10 5-6 p. 413-
1 p.
 artikel
189 10. Randomized clinical trial of post-operative irradiation after surgery for non-small cell lung carcinoma (NSCLC) 1994
 10 5-6 p. 388-389
2 p.
 artikel
190 Randomized phase II trial comparing two chemotherapy combinations for non-small cell lung cancer: Mitomycin, ifosfamide, and cisplatin versus vindesine, ifosfamide, and cisplatin 1994
 10 5-6 p. 417-
1 p.
 artikel
191 Recent studies on bronchiolo-alveolar tumors in mice 1994
 10 5-6 p. 362-363
2 p.
 artikel
192 Reduction of lung diffusion for carbon monoxide in patients with lung carcinoma 1994
 10 5-6 p. 414-
1 p.
 artikel
193 Refinement of an indirect immunotoxin assay of monoclonal antibodies recognising the human small cell lung cancer cluster 2 antigen 1994
 10 5-6 p. 404-
1 p.
 artikel
194 Regulation of E-cadherin-mediated adhesion by muscarinic acetylcholine receptors in small cell lung carcinoma 1994
 10 5-6 p. 406-
1 p.
 artikel
195 Regulation of fetal lung growth and maturation by CD10/neutral endopeptidase 24.11 and endogenous bombesin-like peptides 1994
 10 5-6 p. 372-
1 p.
 artikel
196 Regulation of IGF action in lung tumor cells by membrane and secreted IGF binding protein-2 1994
 10 5-6 p. 367-
1 p.
 artikel
197 Resection of heart and/or great vessels for squamous cell carcinoma of the lung 1994
 10 5-6 p. 393-
1 p.
 artikel
198 Resection of N2/N3 of bronchogenic squamous cell carcinoma 1994
 10 5-6 p. 393-
1 p.
 artikel
199 Responsiveness to multiple neuropeptides: acquisition during bronchial carcinogenesis and regulation in a small cell lung cancer (SCLC) cell line 1994
 10 5-6 p. 353-
1 p.
 artikel
200 Results of early diagnosis and surgical treatment for bronchogenic squamous cell carcinoma 1994
 10 5-6 p. 391-392
2 p.
 artikel
201 Retinoids and tracheobronchial epithelial cell differentiation 1994
 10 5-6 p. 357-358
2 p.
 artikel
202 Risk of male lung cancer attributed to coal combustion indoors in Shanghai 1994
 10 5-6 p. 396-
1 p.
 artikel
203 Risk of mesothelioma after environmental exposure to asbestos 1994
 10 5-6 p. 400-
1 p.
 artikel
204 Role of carbohydrates in cancer 1994
 10 5-6 p. 371-
1 p.
 artikel
205 Role of phototherapy, laser therapy, brachytherapy, and prosthetic stents in the management of lung cancer 1994
 10 5-6 p. 429-
1 p.
 artikel
206 Screening for lung cancer re-examined: A reinterpretation of the Mayo Lung Project randomized trial on lung cancer screening 1994
 10 5-6 p. 396-
1 p.
 artikel
207 Screening lung cancer with sputum cytology by mailed specimens: the Taiwan experience 1994
 10 5-6 p. 386-
1 p.
 artikel
208 Serum immunoassay of a small cell lung cancer associated ganglioside: Development of a sensitive scintillation proximity assay 1994
 10 5-6 p. 413-
1 p.
 artikel
209 Severe coronary artery disease after radiation therapy of the chest and mediastinum: Clinical presentation and treatment 1994
 10 5-6 p. 425-
1 p.
 artikel
210 Sex differences in lung-cancer risk associated with cigarette smoking 1994
 10 5-6 p. 400-
1 p.
 artikel
211 Sleeve lobectomy, segmentectomy, and thoracoscopy in the management of carcinoma of the lung 1994
 10 5-6 p. 416-417
2 p.
 artikel
212 Small cell lung cancer differentiation: Oncogene modulation by all-trans-retinoic acid 1994
 10 5-6 p. 361-362
2 p.
 artikel
213 Somatic genetic changes in dysplasia epithelium of the bronchus 1994
 10 5-6 p. 366-
1 p.
 artikel
214 Squamous metaplasia of the bronchial mucosa and its relationship to smoking 1994
 10 5-6 p. 399-
1 p.
 artikel
215 Staging systems of lung cancer 1994
 10 5-6 p. 412-
1 p.
 artikel
216 Suppression of tumorigenicity of A549 lung adenocarcinoma cells by human chromosomes 3 and 11 introduced via microcell-mediated chromosome transfer 1994
 10 5-6 p. 405-
1 p.
 artikel
217 Surgery for N1 non-small cell lung cancer 1994
 10 5-6 p. 387-
1 p.
 artikel
218 Surgical indication and limit of T4 squamous cell lung cancer 1994
 10 5-6 p. 394-
1 p.
 artikel
219 Surgical therapy for carcinoma of the lung 1994
 10 5-6 p. 430-
1 p.
 artikel
220 Surgical treatment of Pancoast tumor 1994
 10 5-6 p. 415-
1 p.
 artikel
221 Synchronous primary lung cancers 1994
 10 5-6 p. 413-414
2 p.
 artikel
222 Terminal pulmonary infections in patients with lung cancer 1994
 10 5-6 p. 410-
1 p.
 artikel
223 The case for mitomycin in non-small cell lung cancer 1994
 10 5-6 p. 422-
1 p.
 artikel
224 The characteristics of LYR anticancer drugs Yurun, L
 1994
 10 5-6 p. 389-
1 p.
 artikel
225 The clinical implication of neuroendocrine markers in non-small cell lung cancer 1994
 10 5-6 p. 356-357
2 p.
 artikel
226 The clinical meaning of general survey for lung cancer Yurun, L
 1994
 10 5-6 p. 387-
1 p.
 artikel
227 The early detection of squamous cell carcinoma (SCC) Yurun, L
 1994
 10 5-6 p. 386-
1 p.
 artikel
228 The expression of H-like blood group glycolipids in small cell carcinoma of the lung 1994
 10 5-6 p. 402-
1 p.
 artikel
229 The glutathione S-transferase polymorphism as a marker for susceptibility to lung carcinoma 1994
 10 5-6 p. 395-
1 p.
 artikel
230 The indications for postoperative radiotherapy in non small cell lung cancer 1994
 10 5-6 p. 388-
1 p.
 artikel
231 The influence of epidermal growth factor and transforming growth factor-β on the growth properties of human small cell lung cancer cell lines. Correlation to invasivion and retinoblastoma gene expression 1994
 10 5-6 p. 365-
1 p.
 artikel
232 The molecular biology of lung cancer pathogenesis 1994
 10 5-6 p. 406-407
2 p.
 artikel
233 The present situation of diagnosis and treatment of lung cancer in China 1994
 10 5-6 p. 388-
1 p.
 artikel
234 The relationship of quantitative epidermal growth factor receptor expression in non-small cell lung cancer to long term survival 1994
 10 5-6 p. 403-404
2 p.
 artikel
235 The restaging of responding patients with limited small cell lung cancer; Is it really useful? 1994
 10 5-6 p. 414-
1 p.
 artikel
236 The role of bombesin/gastrin-releasing peptide as a growth factor in normal and neoplastic bronchial epithelial cells from human donors 1994
 10 5-6 p. 370-371
2 p.
 artikel
237 The role of bronchoscopy in lung cancer 1994
 10 5-6 p. 415-
1 p.
 artikel
238 The role of transthoracic needle biopsy for the diagnosis and staging of lung cancer 1994
 10 5-6 p. 415-
1 p.
 artikel
239 The rules of LYR anticancer therapy Yurun, L
 1994
 10 5-6 p. 389-
1 p.
 artikel
240 The use of nuclear DNA content to monitor the chemosensitivity of human non-small-cell-lung (NSCLC) and colorectal cancers xenografted onto nude mice 1994
 10 5-6 p. 423-
1 p.
 artikel
241 The value and limitations of 201TI scintigraphy in the evaluation of lung lesions and post-therapy follow-up of primary lung carcinoma 1994
 10 5-6 p. 411-
1 p.
 artikel
242 4th IASLC lung tumor biology workshop 1994
 10 5-6 p. 339-346
8 p.
 artikel
243 Tobacco-specific nitrosamine adducts: Studies in laboratory animals and humans 1994
 10 5-6 p. 398-
1 p.
 artikel
244 Topoisomerase IIα and β gene expression in non-small cell lung cancer 1994
 10 5-6 p. 355-
1 p.
 artikel
245 Transforming growth factor-β and retinoic acid in lung cancer 1994
 10 5-6 p. 357-
1 p.
 artikel
246 Treatment results for 12 cases of early hilar lung cancer with a new applicator of intraluminal irradiation using 192iridium thin wires Fuwa, N.
 1994
 10 5-6 p. 393-
1 p.
 artikel
247 Trend of incidence rate of squamous cell carcinoma of the lung 1994
 10 5-6 p. 390-
1 p.
 artikel
248 Trends in lung cancer mortality in three broad Italian geographical areas between 1969–1987 1994
 10 5-6 p. 398-399
2 p.
 artikel
249 Tumour markers for prediction of survival and monitoring of remission in small cell lung cancer 1994
 10 5-6 p. 414-
1 p.
 artikel
250 Value of serum neuron-specific enolase in nonsmall cell lung cancer 1994
 10 5-6 p. 415-
1 p.
 artikel
251 Variant morphology small cell lung cancer (SCLC): laboratory, morphologic, or clinical reality? 1994
 10 5-6 p. 347-
1 p.
 artikel
252 Vasopressin mRNA and neurophysin-related cell-surface antigen (NRSA) in small-cell carcinoma 1994
 10 5-6 p. 407-
1 p.
 artikel
                             252 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland